Fresenius Medical Care AG
As of Oct 22, 2026, Fresenius Medical Care is in Stage 3, the topping phase, now in week 6 (since Sep 17, 2026). It closed at $22.23, 15.5% below its 52-week high and below its 200-day average, which is falling.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is FMS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
FMS among Medical Care Facilities33rd of 49 by relative strength
All 49 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | AGL | Stage 3 · wk 8 | 98 | +6.8% |
| 2 | PACS | Stage 3 · wk 4 | 98 | +15.7% |
| 3 | LFST | Stage 2 · wk 24 | 97 | +4.0% |
| 4 | AMN | Stage 2 · wk 25 | 96 | +38.1% |
| 5 | NHC | Stage 2 · wk 59 | 95 | +8.4% |
| 6 | CON | Stage 2 · wk 22 | 94 | +14.9% |
| 7 | INNV | Stage 3 · wk 5 | 93 | +5.8% |
| 8 | MD | Stage 2 · wk 26 | 92 | +14.3% |
| …33 | FMS | Stage 3 · wk 6 | 43 | −0.8% |
Fresenius Medical Care: quick answers
What stage is Fresenius Medical Care in?
As of Oct 22, 2026, Fresenius Medical Care (FMS) is in Stage 3, the topping phase. It entered Stage 3 on Sep 17, 2026 and is in week 6. What the four stages mean
Is Fresenius Medical Care in an uptrend?
Its uptrend has stalled. Fresenius Medical Care is in Stage 3, the topping phase that follows an advance. It trades 1.0% below its 200-day average, which is falling.
How far is Fresenius Medical Care from its 52-week high?
Fresenius Medical Care closed at $22.23 on Oct 22, 2026, 15.5% below its 52-week high of $26.31. Its 52-week low is $19.41.
How has Fresenius Medical Care performed over the past year?
As of Oct 22, 2026, Fresenius Medical Care is down 14.7% over the past year and down 1.6% so far in 2026.
Which sector and industry is Fresenius Medical Care in?
Fresenius Medical Care is in the Medical Care Facilities industry, part of the Health Care sector.
About this companyHealth Care· Medical Care Facilities
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.